⌘K
Loading ticker…
Zenas BioPharma, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Zenas BioPharma, Inc. Common Stock (ZBIO) has a 3-month relative strength percentile of 67 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.9%, relative volume 4.82×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
67 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ZBIO is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 33.5% / 4.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ZBIO is held by 5 ETFs as of Mar 2026. Top owner: XBI at 0.24% weight, $18M notional. Top 3 carry $46M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.24% | $18M |
| VTIVanguard Total Stock Market ETF | 0.00% | $17M |
| IWMiShares Russell 2000 ETF | 0.02% | $11M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $653K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBIO Jan avg: -25.74% median: -25.74% win: 0% σ: 33.47% n: 2 2024-09-16 → 2026-05-29 | ZBIO Feb avg: 15.42% median: 15.42% win: 50% σ: 39.62% n: 2 2024-09-16 → 2026-05-29 | ZBIO Mar avg: -6.55% median: -6.55% win: 50% σ: 27.22% n: 2 2024-09-16 → 2026-05-29 | ZBIO Apr avg: 22.70% median: 22.70% win: 50% σ: 33.77% n: 2 2024-09-16 → 2026-05-29 | ZBIO May avg: -11.28% median: -11.28% win: 0% σ: 9.21% n: 2 2024-09-16 → 2026-05-29 | ZBIO Jun avg: 1.79% median: 1.79% win: 100% σ: 0.00% n: 1 2024-09-16 → 2026-05-29 (current) | ZBIO Jul avg: 62.13% median: 62.13% win: 100% σ: 0.00% n: 1 2024-09-16 → 2026-05-29 | ZBIO Aug avg: 1.85% median: 1.85% win: 100% σ: 0.00% n: 1 2024-09-16 → 2026-05-29 | ZBIO Sep avg: 15.99% median: 15.99% win: 50% σ: 32.19% n: 2 2024-09-16 → 2026-05-29 | ZBIO Oct avg: 33.13% median: 33.13% win: 100% σ: 10.79% n: 2 2024-09-16 → 2026-05-29 | ZBIO Nov avg: -10.77% median: -10.77% win: 50% σ: 49.54% n: 2 2024-09-16 → 2026-05-29 | ZBIO Dec avg: -17.67% median: -17.67% win: 0% σ: 15.81% n: 2 2024-09-16 → 2026-05-29 |